Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action.
Saved in:
| Title: | Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action. |
|---|---|
| Authors: | Steinman JB; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States., Santarossa CC; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States., Miller RM; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States., Yu LS; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States., Serpinskaya AS; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, United States., Furukawa H; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Morimoto S; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Tanaka Y; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Nishitani M; Pharmaceutical Research Division, Takeda Pharmaceuticals Ltd, Kanagawa, Japan., Asano M; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Zalyte R; Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom., Ondrus AE; Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States., Johnson AG; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States., Ye F; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States., Nachury MV; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States., Fukase Y; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Aso K; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Foley MA; Tri-Institutitional Therapeutics Discovery Institute, New York, United States., Gelfand VI; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, United States., Chen JK; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States., Carter AP; Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom., Kapoor TM; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States. |
| Source: | ELife [Elife] 2017 May 19; Vol. 6. Date of Electronic Publication: 2017 May 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28524820 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Steinman+JB%22">Steinman JB</searchLink>; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States.<br /><searchLink fieldCode="AU" term="%22Santarossa+CC%22">Santarossa CC</searchLink>; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States.<br /><searchLink fieldCode="AU" term="%22Miller+RM%22">Miller RM</searchLink>; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States.<br /><searchLink fieldCode="AU" term="%22Yu+LS%22">Yu LS</searchLink>; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States.<br /><searchLink fieldCode="AU" term="%22Serpinskaya+AS%22">Serpinskaya AS</searchLink>; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, United States.<br /><searchLink fieldCode="AU" term="%22Furukawa+H%22">Furukawa H</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Morimoto+S%22">Morimoto S</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Tanaka+Y%22">Tanaka Y</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Nishitani+M%22">Nishitani M</searchLink>; Pharmaceutical Research Division, Takeda Pharmaceuticals Ltd, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Asano+M%22">Asano M</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Zalyte+R%22">Zalyte R</searchLink>; Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ondrus+AE%22">Ondrus AE</searchLink>; Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States.<br /><searchLink fieldCode="AU" term="%22Johnson+AG%22">Johnson AG</searchLink>; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States.<br /><searchLink fieldCode="AU" term="%22Ye+F%22">Ye F</searchLink>; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States.<br /><searchLink fieldCode="AU" term="%22Nachury+MV%22">Nachury MV</searchLink>; Department of Molecular and Cellular Physiology, Stanford University, Stanford, United States.<br /><searchLink fieldCode="AU" term="%22Fukase+Y%22">Fukase Y</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Aso+K%22">Aso K</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Foley+MA%22">Foley MA</searchLink>; Tri-Institutitional Therapeutics Discovery Institute, New York, United States.<br /><searchLink fieldCode="AU" term="%22Gelfand+VI%22">Gelfand VI</searchLink>; Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, United States.<br /><searchLink fieldCode="AU" term="%22Chen+JK%22">Chen JK</searchLink>; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, United States.<br /><searchLink fieldCode="AU" term="%22Carter+AP%22">Carter AP</searchLink>; Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kapoor+TM%22">Kapoor TM</searchLink>; Laboratory of Chemistry and Cell Biology, Rockefeller University, New York, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2017 May 19; Vol. 6. <i>Date of Electronic Publication: </i>2017 May 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28524820 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.25174 Languages: – Code: eng Text: English Titles: – TitleFull: Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Steinman JB – PersonEntity: Name: NameFull: Santarossa CC – PersonEntity: Name: NameFull: Miller RM – PersonEntity: Name: NameFull: Yu LS – PersonEntity: Name: NameFull: Serpinskaya AS – PersonEntity: Name: NameFull: Furukawa H – PersonEntity: Name: NameFull: Morimoto S – PersonEntity: Name: NameFull: Tanaka Y – PersonEntity: Name: NameFull: Nishitani M – PersonEntity: Name: NameFull: Asano M – PersonEntity: Name: NameFull: Zalyte R – PersonEntity: Name: NameFull: Ondrus AE – PersonEntity: Name: NameFull: Johnson AG – PersonEntity: Name: NameFull: Ye F – PersonEntity: Name: NameFull: Nachury MV – PersonEntity: Name: NameFull: Fukase Y – PersonEntity: Name: NameFull: Aso K – PersonEntity: Name: NameFull: Foley MA – PersonEntity: Name: NameFull: Gelfand VI – PersonEntity: Name: NameFull: Chen JK – PersonEntity: Name: NameFull: Carter AP – PersonEntity: Name: NameFull: Kapoor TM IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 05 Text: 2017 May 19 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 6 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |